U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06866236) titled 'Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression' on March 04.
Brief Summary: Chronic kidney disease CKD is estimated to affect nearly over 800 million people globally today (with roughly 125,000 people ending up annually on dialysis in the United States alone. CKD is a contributor to illness and is associated with a diminished quality of life and reduced life expectancy . In this study we are using a novel drug to target improved function of the kidneys.
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
Chronic Kidney Diseases
Acute Kidney Injury
Kidney Failure
Interven...